StockData
SBFMNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as SBFMW

Sunshine Biopharma Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.24+0.02 (+9.02%)

Close on Oct 19, 2026

Market cap
$330.14K
P/E (TTM)
–
Dividend yield
–

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
0M
Shares held, 13F filers
Institutional holders
9
9 new, 0 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
BJI Financial Group909,9006.00%13G (passive)Oct 8, 2026
Mitchell P. Kopin505,6539.99%13G (passive)May 19, 2025
Bigger Capital Fund L P297,1018.17%13G (passive)Apr 2, 2025
Intracoastal Capital LLC235,6979.99%13G (passive) amendmentJun 30, 2026
Bigger Michael1,610,0009.47%13G (passive)May 18, 2026
CVI Investments, Inc.1,588,2669.90%13G (passive)Oct 8, 2026

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of SBFMValueChange% of portfolio
Jane Street Group, LLC14,974–$31.45KNew0.00%
Morgan Stanley385–$808New0.00%
SBI Securities Co., Ltd.162–$340New0.00%
National Bank Of Canada /Fi/5–$10New0.00%
Osaic Holdings, Inc.2–$4New0.00%
Caitong International Asset Management Co., Ltd1–$2New0.00%
Farther Finance Advisors, LLC1–$2New0.00%
Strive Financial Group ,LLC1–$2New0.00%
TD Waterhouse Canada Inc.1–$2New0.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares heldNew / addedReduced / closedShares boughtShares sold
Q2 202690M9 / 00 / 00M0M

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares ownedLatest filing
Michel RoyChief Commercial Officer1Jan 21, 2025
David NatanDirector68,300Aug 11, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
David Natan
Director
Aug 7, 2026Award+58,300––68,300
David Natan
Director
Apr 14, 2026Award+100,000––100,000
Steve N. Slilaty
Chief Executive Officer, Director, 10% owner
Mar 4, 2024Buy+100,000$0.10$10.00K130,000
Steve N. Slilaty
Chief Executive Officer, Director, 10% owner
Feb 8, 2024Buy+20,000$0.10$2.00K30,000
Camille Sebaaly
CFO/Secretary
Nov 30, 2022Buy+30,000$0.76$22.80K174,465
Camille Sebaaly
CFO/Secretary
Jun 3, 2022Buy+25,000$1.22$30.50K144,465
Steve N. Slilaty
Chief Executive Officer, Director
Feb 18, 2022Returned to company−990,000$0.10$99.00K10,000
Abderrazzak Merzouki
Chief Operating Officer, Director
Jan 6, 2021Award+20,000,000––23,342,500
Steve N. Slilaty
Chief Executive Officer, Director
Jan 6, 2021Award+20,000,000––23,343,461
Camille Sebaaly
CFO/Secretary, Director
Jan 6, 2021Award+20,000,000––23,893,086
Steve N. Slilaty
Chief Executive Officer, Director
Jun 17, 2020Award+500,000$0.10$50.00K1,000,000
Camille Sebaaly
CFO/Secretary, Director
Dec 31, 2019Award−323,673––0
Steve N. Slilaty
Chief Executive Officer, Director
Dec 31, 2019Other+323,673––861,209
Camille Sebaaly
CFO/Secretary, Director
Dec 19, 2019Award+1,300,000––3,893,086
Abderrazzak Merzouki
Chief Operating Officer, Director
Dec 19, 2019Award+1,300,000––3,342,500
Steve N. Slilaty
Chief Executive Officer, Director
Dec 19, 2019Award+1,300,000––3,343,461
Camille Sebaaly
CFO/Secretary, Director
Oct 20, 2019Award+1,100,000––2,593,086
Abderrazzak Merzouki
Chief Operating Officer, Director
Oct 20, 2019Award+1,100,000––2,042,500
Steve N. Slilaty
Chief Executive Officer, Director
Oct 20, 2019Award+1,100,000––2,043,461
Camille Sebaaly
CFO/Secretary, Director
Sep 11, 2019Award+550,000––1,493,086
Camille Sebaaly
Secretary, Director, 10% owner
Sep 11, 2019Award+11,000,000––29,861,719
Abderrazzak Merzouki
Chief Operating Officer, Director
Sep 2, 2019Award+13,000,000––18,850,000
Steve N. Slilaty
Chief Executive Officer, Director, 10% owner
Sep 2, 2019Award+13,000,000––18,869,219
Camille Sebaaly
Secretary, Director, 10% owner
Sep 2, 2019Award+13,000,000––18,861,719
Abderrazzak Merzouki
Chief Operating Officer, Director
Aug 27, 2018Award+38,000,000––117,000,000
Steve N. Slilaty
Chief Executive Officer, Director
Aug 27, 2018Award+38,000,000––117,384,373
Abderrazzak Merzouki
Chief Operating Officer, Director
Aug 27, 2018Award+38,000,000––118,467,000
Camille Sebaaly
Secretary, Director
Aug 27, 2018Award+38,000,000––117,234,373
Abderrazzak Merzouki
Chief Operating Officer, Director
Jun 20, 2018Award+27,000,000––79,000,000
Steve N. Slilaty
Chief Executive Officer, Director
Jun 20, 2018Award+27,000,000––79,384,373
Camille Sebaaly
Secretary, Director
Jun 20, 2018Award+27,000,000––79,234,373
Abderrazzak Merzouki
Chief Operating Officer, Director
Jun 20, 2018Award+27,000,000––80,467,000
Abderrazzak Merzouki
Chief Operating Officer, Director
Apr 22, 2018Award+12,000,000––12,000,000
Abderrazzak Merzouki
Chief Operating Officer, Director
Jul 20, 2017Award+14,000,000––52,000,000
Steve N. Slilaty
Chief Executive Officer, Director
Jul 20, 2017Award+14,000,000––52,384,373
Abderrazzak Merzouki
Chief Operating Officer, Director
Jul 20, 2017Award+14,000,000––53,467,000
Camille Sebaaly
Secretary, Director
Jul 20, 2017Award+14,000,000––52,234,373
Abderrazzak Merzouki
Chief Operating Officer, Director
Dec 6, 2016Award+28,000,000––38,000,000
Abderrazzak Merzouki
Chief Operating Officer, Director
Dec 6, 2016Award+26,000,000––39,467,000
Camille Sebaaly
CFO and Secretary, Director
Dec 6, 2016Award+26,000,000––38,234,373
Steve N. Slilaty
Chief Executive Officer, Director
Dec 6, 2016Award+26,000,000––38,384,373
Camille Sebaaly
CFO and Secretary, Director, 10% owner
Oct 10, 2016Other+129,468,927––129,468,927
Corp Advanomics
10% owner
Oct 10, 2016Other−136,861,968––215,014,224
Steve N. Slilaty
Chief Executive Officer, Director, 10% owner
Oct 10, 2016Other−136,861,968––215,014,224
Steve N. Slilaty
Chief Executive Officer, Director, 10% owner
Jul 8, 2016Other+321,305,416––351,876,192
Steve N. Slilaty
Chief Executive Officer, Director
Apr 22, 2016Award+12,000,000$0.01$120.00K12,384,373
Camille Sebaaly
CFO and Secretary, Director
Apr 22, 2016Award+12,000,000$0.01$120.00K12,234,373
Abderrazzak Merzouki
Chief Operating Officer, Director
Apr 22, 2016Award+12,000,000$0.01$120.00K13,467,000
Steve N. Slilaty
Chief Executive Officer, Director
Apr 12, 2016Buy+253,082$0.20$50.62K30,570,776
Steve N. Slilaty
Chief Executive Officer, Director, 10% owner
May 27, 2015Buy+500,000$0.10$50.00K500,000
Steve N. Slilaty
Chief Executive Officer, Director, 10% owner
Jan 9, 2015Other+150,000$0.02$3.00K384,373
Steve N. Slilaty
Chief Executive Officer, Director, 10% owner
Jan 9, 2015Other−1,200,000$0.02$24.00K30,317,694
Steve N. Slilaty
Chief Executive Officer, Director, 10% owner
Sep 4, 2012Other−2,591,500$0.05$129.58K31,517,694
Steve N. Slilaty
Chief Executive Officer, Director, 10% owner
Sep 4, 2012Sale−2,591,500$0.05$129.58K31,517,694
Steve N. Slilaty
Chief Executive Officer, Director, 10% owner
Dec 21, 2011Conversion+17,000,000––34,109,194
Steve N. Slilaty
Chief Executive Officer, Director, 10% owner
Dec 21, 2011Conversion+17,000,000––34,109,194

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.